Wealth Enhancement Advisory Services »

Apellis Pharmaceuticals shares owned by Wealth Enhancement Advisory Services

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Wealth Enhancement Advisory Services from 13F filings

Historical chart of Wealth Enhancement Advisory Services investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Wealth Enhancement Advisory Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.0M 78k 25.21
2025-06-30 $1.8M 101k 18.26
2025-03-31 $1.5M 70k 21.87
2024-12-31 $1.1M 34k 31.91

More positions owned by Wealth Enhancement Advisory Services

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Alps Etf Tr Smith Core Plus (SMTH)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Msci Intl Moment (IMTM)
Amazon (AMZN)
J P Morgan Exchange Traded F Us Momentum (JMOM)
Schwab Strategic Tr Fundamental Intl (FNDF)
Victory Portfolios Ii Usaa Msci Usa Sm (USVM)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Ishares Tr Msci Usa Min Vol (USMV)
Ishares Tr Us Treas Bd Etf (GOVT)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Wealth Enhancement Advisory Services

Top funds holding Apellis Pharmaceuticals

venBio Select Advisor
Vanguard Group
Morgan Stanley
Wellington Management Company
Deep Track Capital
BlackRock
AQR Capital Management
Jennison Associates
State Street Corporation
EcoR1 Capital
UBS Group
Suvretta Capital Management
Polar Capital Holdings
Siren
OrbiMed Advisors

View all funds holding Apellis Pharmaceuticals